← All stocks

electroCore, Inc.

ECOR Net buying
CIK 0001560258 #4390 in the set updated 17 Sep 2026
Bought (120 mo)
$6.15M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.49M
$0.00 on a plan · $200.12K straight out of an exercise
Sold at will
$1.29M
13 of 16 sales
Net
+$4.67M
+$4.87M against sales at will

By person

22 insiders · 88 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Merck Global Health Innovation Fund, LLC entity
10% owner
$2.50M (1)
+$2.50M
3,346,032
37.11%
$31.32M
+5.2%
TULLIS JAMES L L
Director
$1.59M (3)
+$1.59M
2,014,110
22.34%
$18.85M
+2,158%
Errico Thomas J.
Director
$694.50K (17)
+$694.50K
1,063,994
11.80%
$9.96M
+1,107%
Lev Joshua S.
See Remarks
$305.63K (7) scheduled
−$305.63K
139,889
1.55%
$1.31M
+756.5%
Errico Joseph P
Director
$278.08K (10)
$535.27K (6)
−$257.20K
3,861,942
42.83%
$36.15M
+32.9%
Moody Trevor J
Director
$221.12K (4)
+$221.12K
67,592
0.7497%
$632.66K
COX CARRIE SMITH
Director
$118.71K (4)
+$118.71K
21,000
0.2329%
$196.56K
Amato Francis R.
Chief Executive Officer
$49.01K (1)
+$49.01K
368,355
4.09%
$3.45M
+2.1%
Staats Peter S.
Chief Medical Officer
$48.30K (1)
+$48.30K
476,419
5.28%
$4.46M
+4.1%
Goldberger Daniel S
Former Officer & Director
$595.14K (21)
$640.75K (2)
−$45.61K
211,471
2.35%
$1.98M
GANDOLFO JOHN P
Director
$29.45K (4)
+$29.45K
99,221
1.10%
$928.71K
POSNER BRIAN M
Chief Financial Officer
$34.33K (4)
$5.96K (1)
+$28.37K
22,437
0.2489%
$210.01K
Core Ventures II, LLC entity
10% owner
646,342
7.17%
$6.05M
−91.6%
Theofilos Charles Steve
Former director
454,202
5.04%
$4.25M
+10.1%
Fox Michael
See Remarks
130,000
1.44%
$1.22M
Vraniak Glenn S.
Chief Financial Officer
120,811
1.34%
$1.13M
+2.5%
Goldstein Julie Ann
Director
112,510
1.25%
$1.05M
PATTON THOMAS M
Director
102,782
1.14%
$962.04K
Wilber Patricia
Director
83,448
0.9256%
$781.07K
Bonfiglioli Elena
Director
41,672
0.4622%
$390.05K
Theofilos James Charles
Director
34,670
0.3845%
$324.51K
+2,392%
CUNEO F PETER
Director
5,665
0.0628%
$53.02K
Insider
Date
Role
Action
Shares
Price
Amount
Errico Thomas J.
19 Mar 2026
Director
Exercised, kept
19,252
$6.43
$123.79K
Errico Thomas J.
19 Mar 2026
Director
Exercised, kept
22,803
$4.35
$99.19K

What was left out

Form 4 filings counted 174
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 3
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 10,052,623
Sales filed before the plan box existed 7
History held since 22 Jun 2018